医药是过去5 年间天猫“双11”成交额增速最快的板块。阿里健康发布数据显示：2018 天猫“双11”开场仅30 分钟，天猫医美平台成交额就超去年双11全天；1 小时04 分，包括体检、医美、口腔在内的医疗服务超过去年双11 全天；9 小时52 分，天猫医药成交额超过去年双11 全天。10 月底，电商平台“黑马”拼多多也被报道试水医药电商。这些使得“药流通环节的互联网+”再次成为了受到投资人最多关注的热点领域之一。

Sixth smallest market in the CEE region. Per capita spending is well above regional average. Market will record a mid single-digit US dollar CAGR. Other medical devices and consumables have the largest market shares. Most requirements are imported, largely from other EU countries. Local production of basic items is strong but geared to exports. Comprehensive public health insurance system. Relatively robust private health insurance sector. Slovenia has long had a good reputation in specialist areas such as dentistry, attracting patients from neighbouring countries.

One of the largest markets in the Middle East & Africa (MEA) region, similar in size to Iran. Market size is supported by a large population and Africa's most industrialised economy. Owing to the size of the population, per capita spending is low. Spending on medical devices as a proportion of wealth is below average for the MEA region. Other medical devices accounts for nearly 40% of the total market. Underdeveloped market offers considerable potential for growth but currently constrained by funding issues, poor infrastructure and staff shortages. National Health Insurance programme in the early stages of implementation, but question marks remain on funding and delivery of key targets. Limited medical device production, therefore market largely dependent on imports.

South Africa's pharmaceutical market is the single largest on the African continent. Its pharmaceutical spending per capita is high for an African country - at USD57 in 2017. We forecast South Africa's total pharmaceutical expenditure to increase from ZAR43.3bn (USD3.2bn) in 2017 to ZAR45.4bn (USD3.4bn) in 2018, equating to growth of 4.8% and 5.6% in local currency and US dollar terms respectively. Total pharmaceutical expenditure was equivalent to 0.9% of GDP and 11.1% of total healthcare expenditure in 2017. South Africa's pharmaceutical market is dominated by prescription drug spending, including patented and generic drug expenditure, which accounts for approximately 88.3% of the total market. Over-the-counter (OTC) medicine spending represents the remainder of 11.5%. Of the three sub-divisions, patented medicines represent the largest single segment of the total market by value, at approximately 52.8% in 2017, followed by generic drug spending with 35.5% of total medicines spending.

South Africa's pharmaceutical market is the single largest on the African continent. Its pharmaceutical spending per capita is high for an African country - at USD57 in 2017. We forecast South Africa's total pharmaceutical expenditure to increase from ZAR43.3bn (USD3.2bn) in 2017 to ZAR45.4bn (USD3.4bn) in 2018, equating to growth of 4.8% and 5.6% in local currency and US dollar terms respectively. Total pharmaceutical expenditure was equivalent to 0.9% of GDP and 11.1% of total healthcare expenditure in 2017. South Africa's pharmaceutical market is dominated by prescription drug spending, including patented and generic drug expenditure, which accounts for approximately 88.3% of the total market. OTC medicine spending represents the remainder of 11.5%. Of the three sub-divisions, patented medicines represent the largest single segment of the total market by value, at approximately 52.8% in 2017, followed by generic drug spending with 35.5% of total medicines spending.